GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Trulieve Cannabis Corp (OTCPK:TCNNF) » Definitions » Beneish M-Score

Trulieve Cannabis (Trulieve Cannabis) Beneish M-Score : -2.39 (As of Apr. 29, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Trulieve Cannabis Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.39 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Trulieve Cannabis's Beneish M-Score or its related term are showing as below:

TCNNF' s Beneish M-Score Range Over the Past 10 Years
Min: -3.17   Med: -1.05   Max: 4.88
Current: -2.39

During the past 10 years, the highest Beneish M-Score of Trulieve Cannabis was 4.88. The lowest was -3.17. And the median was -1.05.


Trulieve Cannabis Beneish M-Score Historical Data

The historical data trend for Trulieve Cannabis's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Trulieve Cannabis Beneish M-Score Chart

Trulieve Cannabis Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.70 -1.05 4.88 -3.17 -2.39

Trulieve Cannabis Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.17 -3.22 -3.35 -3.47 -2.39

Competitive Comparison of Trulieve Cannabis's Beneish M-Score

For the Drug Manufacturers - Specialty & Generic subindustry, Trulieve Cannabis's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Trulieve Cannabis's Beneish M-Score Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Trulieve Cannabis's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Trulieve Cannabis's Beneish M-Score falls into.



Trulieve Cannabis Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Trulieve Cannabis for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.9338+0.528 * 1.0839+0.404 * 0.9347+0.892 * 0.9246+0.115 * 0.9446
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.935+4.679 * -0.146288-0.327 * 0.9557
=-2.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was $13 Mil.
Revenue was 286.974 + 275.21 + 281.795 + 289.089 = $1,133 Mil.
Gross Profit was 153.853 + 142.946 + 141.607 + 149.938 = $588 Mil.
Total Current Assets was $477 Mil.
Total Assets was $2,729 Mil.
Property, Plant and Equipment(Net PPE) was $831 Mil.
Depreciation, Depletion and Amortization(DDA) was $181 Mil.
Selling, General, & Admin. Expense(SGA) was $388 Mil.
Total Current Liabilities was $115 Mil.
Long-Term Debt & Capital Lease Obligation was $770 Mil.
Net Income was -33.431 + -25.392 + -403.849 + -64.124 = $-527 Mil.
Non Operating Income was -7.063 + 12.423 + -308.924 + -25.845 = $-329 Mil.
Cash Flow from Operations was 131.464 + 93.439 + -23.472 + 0.41 = $202 Mil.
Total Receivables was $7 Mil.
Revenue was 298.476 + 295.353 + 313.839 + 317.747 = $1,225 Mil.
Gross Profit was 157.11 + 168.712 + 183.373 + 180.456 = $690 Mil.
Total Current Assets was $594 Mil.
Total Assets was $3,400 Mil.
Property, Plant and Equipment(Net PPE) was $913 Mil.
Depreciation, Depletion and Amortization(DDA) was $186 Mil.
Selling, General, & Admin. Expense(SGA) was $449 Mil.
Total Current Liabilities was $210 Mil.
Long-Term Debt & Capital Lease Obligation was $943 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(12.936 / 1133.068) / (7.235 / 1225.415)
=0.011417 / 0.005904
=1.9338

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(689.651 / 1225.415) / (588.344 / 1133.068)
=0.56279 / 0.519249
=1.0839

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (477.348 + 830.799) / 2729.055) / (1 - (593.543 + 912.681) / 3400.405)
=0.520659 / 0.557046
=0.9347

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=1133.068 / 1225.415
=0.9246

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(185.569 / (185.569 + 912.681)) / (180.99 / (180.99 + 830.799))
=0.168968 / 0.178881
=0.9446

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(387.812 / 1133.068) / (448.554 / 1225.415)
=0.342267 / 0.366043
=0.935

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((769.64 + 114.849) / 2729.055) / ((942.854 + 210.295) / 3400.405)
=0.324101 / 0.339121
=0.9557

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-526.796 - -329.409 - 201.841) / 2729.055
=-0.146288

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Trulieve Cannabis has a M-score of -2.34 suggests that the company is unlikely to be a manipulator.


Trulieve Cannabis Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Trulieve Cannabis's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Trulieve Cannabis (Trulieve Cannabis) Business Description

Traded in Other Exchanges
Address
6749 Ben Bostic Road, Quincy, FL, USA, 32351
Trulieve Cannabis Corp is a vertically integrated seed to sale and fully licensed medical marijuana company. It is mainly engaged in the cultivation, possession, use, sale, and distribution of medical cannabis.
Executives
Timothy E Mullany officer: Chief Financial Officer 3551 PLANO PARKWAY, THE COLONY TX 75056
Ryan Blust officer: Chief Financial Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Joy Malivuk officer: Chief Accounting Officer 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Peter Healy director C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Rebecca L. Young officer: Chief Accounting Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kim A. Rivers director, 10 percent owner, officer: Chief Executive Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Thomas L Millner director, 10 percent owner
Thad Beshears director, 10 percent owner C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Kyle Landrum officer: Chief Production Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Timothy Morey officer: Chief Sales Officer C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Eric Powers officer: GC and Corporate Secretary C/O TRULIEVE CANNABIS CORP., 6749 BEN BOSTIC ROAD, QUINCY FL 32351
Susan Thronson director C/O ANGIE'S LIST, INC., 1030 E. WASHINGTON STREET, INDIANPOLIS IN 46202
Alex D'amico officer: Chief Financial Officer 10 EAST PASSAIC AVENUE, UNIT C-2, NUTLEY NJ 07110
Giannella Alvarez director C/O DOMTAR CORPORATION, 234 KINGSLEY PARK DRIVE, FORT MILL SC 29715
Jane C Morreau director